Table 2. Summary of the political declarations and roadmap for access to medicines from 2000-till date .
| Global organization/ Authority | Resolution/year | Topic/Area |
| OHCHR | High Commissioner Report on COVID-19 vaccines (2022). Ref: A/HRC/49/35 |
“The human rights implications of the lack of affordable, timely, equitable, and universal access and distribution of COVID-19 vaccines.” The growing disparities across states underline the fact that vaccine delays have serious health impacts as well as fundamental human rights implications. |
| WHO | The 71st WHA’s Director General’s Report Ref: (document A71/12). May 2018, | “Addressing global medicine and vaccine shortages and improving access”- “Road map for access to medicines, vaccines, and other related health products 2019–2023” |
| OHCHR report | A/HRC/47/23, May 2021 | “The State's crucial role in addressing pandemics and other health emergencies, as well as the socioeconomic fallout from doing so, in promoting sustainable development and the realization of all human rights” |
| OHCHR report | Ref: A/HRC/46/19, March 2021 | “COVID-19 pandemic’s impact on the enjoyment of human rights worldwide, good practices and the areas of concern” |
| HRC | HRC resolution Ref: 46/14 of 29 dated March 2021 | “To ensure equitable, affordable, timely, and universal access vaccines for all countries in response to COVID-19” |
| HRC | HRC resolution Ref: 41/10 of 19 dated July 2019 | “Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.” |
| UNGA | General Assembly’s resolution Ref: 73/3 dated 10 October 2018 | “Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis.” |
| UNGA | General Assembly’s resolution Ref: 73/2 dated 10 October 2018 | “Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases” |
| UNGA | General Assembly’s resolution Ref: 71/3 of 5 dated October 2016 | “Political declaration of the high-level meeting of the General Assembly on antimicrobial resistance.” |
| UN Secretary-General | High-level Panel of United Nations Secretary-General dated September 2016 | A web gage on access to medicines and the Panel’s report on “promoting innovation and access to health technologies” |
| HRC | HRC’s resolution Ref: 32/15 dated 1 July 2016 | “Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health” |
| UNGA | General Assembly’s resolution Ref: 70/1 dated 25 September 2015 | “Transforming our world: the 2030 Agenda for Sustainable Development.” |
| HRC Social Forum | A/HRC/29/44 of 2015 | “Report of the 2015 Social Forum on Access to Medicines” |
| HRC Special Rapporteur | A/HRC/23/42), 1 May 2013 | “Right of everyone to the enjoyment of the highest attainable standard of physical and mental health.” |
| HRC Special Rapporteur | A/63/263), 11 August 2008 | “Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines” |
| Committee on Economic, Social and Cultural Rights | CESCR, General comments Ref: No. 17 (2006) | “The responsibilities of States parties to prevent high costs of essential medicines, plant seeds and food production from undermining the rights to health, food, and education.” |
| Committee on Economic, Social and Cultural Rights | CESCR, General comments Ref: No. 14 (2000) | Within the control of the State party, health facilities, goods, and services must be accessible to all without discrimination. The four overlapping dimensions of accessibility include Non-discrimination, accessibility in physical, Economic and information domains |
Abbreviations: OHCHR, Commissioner of Office of the High Commissioner for Human Rights; WHO, World Health Organization; UNGA, United Nations General Assembly; HRC, Human Rights Council.